Triple O Research Institute, P.A ( Site 5666) — West Palm Beach, Florida

Public research footprint of Triple O Research Institute, P.A ( Site 5666), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Completed

Stopped or withdrawn

Most-studied conditions

HIV-1 Infection · HIV-1/HBV Co-Infection · SARS-CoV-2 · COVID-19 Pneumonia

Recently updated registry entries

NCT06333808 — Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who… (Active Not Recruiting)
NCT04233879 — Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral… (Completed)
NCT06630299 — Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Triple O Research Institute, P.A ( Site 5666)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.